Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Characterization of human amniotic fluid stem cells and their pluripotential capability.

Perin L, Sedrakyan S, Da Sacco S, De Filippo R.

Methods Cell Biol. 2008;86:85-99. doi: 10.1016/S0091-679X(08)00005-8.

PMID:
18442645
2.

Amniotic fluid-derived stem cells in regenerative medicine research.

Joo S, Ko IK, Atala A, Yoo JJ, Lee SJ.

Arch Pharm Res. 2012 Feb;35(2):271-80. doi: 10.1007/s12272-012-0207-7. Epub 2012 Feb 28. Review.

PMID:
22370781
3.

Isolation of amniotic stem cell lines with potential for therapy.

De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A.

Nat Biotechnol. 2007 Jan;25(1):100-6. Epub 2007 Jan 7.

PMID:
17206138
4.

Renal differentiation of amniotic fluid stem cells.

Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, Habibian R, Warburton D, Atala A, De Filippo RE.

Cell Prolif. 2007 Dec;40(6):936-48.

PMID:
18021180
5.

Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility.

Lai D, Wang F, Chen Y, Wang L, Wang Y, Cheng W.

BMC Dev Biol. 2013 Sep 4;13:34. doi: 10.1186/1471-213X-13-34.

6.

Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy.

Antonucci I, Stuppia L, Kaneko Y, Yu S, Tajiri N, Bae EC, Chheda SH, Weinbren NL, Borlongan CV.

Cell Transplant. 2011;20(6):789-95. doi: 10.3727/096368910X539074. Epub 2010 Nov 5.

PMID:
21054947
7.

Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells.

Decembrini S, Cananzi M, Gualdoni S, Battersby A, Allen N, Pearson RA, Ali RR, De Coppi P, Sowden JC.

Stem Cells Dev. 2011 May;20(5):851-63. doi: 10.1089/scd.2010.0291. Epub 2010 Dec 6.

PMID:
20939691
8.

Clone-derived human AF-amniotic fluid stem cells are capable of skeletal myogenic differentiation in vitro and in vivo.

Ma X, Zhang S, Zhou J, Chen B, Shang Y, Gao T, Wang X, Xie H, Chen F.

J Tissue Eng Regen Med. 2012 Aug;6(8):598-613. doi: 10.1002/term.462. Epub 2012 Mar 7.

PMID:
22396316
9.

Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential.

Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, Soligo D, Bosari S, Silani V, Deliliers GL, Rebulla P, Lazzari L.

Cell Res. 2006 Apr;16(4):329-36.

10.

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, Atala A, Gagliardini E, Xinaris C, Benedetti V, Fabricio AS, Squarcina E, Abbate M, Benigni A, Remuzzi G, Morigi M.

Stem Cells Dev. 2012 Jul 20;21(11):1911-23. doi: 10.1089/scd.2011.0333. Epub 2011 Dec 23.

11.

Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations.

Bottai D, Cigognini D, Nicora E, Moro M, Grimoldi MG, Adami R, Abrignani S, Marconi AM, Di Giulio AM, Gorio A.

Restor Neurol Neurosci. 2012;30(1):55-68. doi: 10.3233/RNN-2011-0620.

PMID:
22377907
12.

[Isolation and biological characterization of human amniotic fluid-derived stem cells].

Guan T, Chen XL, Wei YJ, Lai Y, Xie LY, Liu ZY, Zhang XM, Liu HQ, Zhang JJ, Xie XY, Liu SL.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;43(1):15-8. Chinese.

PMID:
22455123
13.

Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?

Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M.

Hum Reprod. 2003 Jul;18(7):1489-93.

PMID:
12832377
14.

Derivation and characterization of progenitor stem cells from canine allantois and amniotic fluids at the third trimester of gestation.

Fernandes RA, Wenceslau CV, Reginato AL, Kerkis I, Miglino MA.

Placenta. 2012 Aug;33(8):640-4. doi: 10.1016/j.placenta.2012.03.009. Epub 2012 May 3.

16.

Low microRNA-199a expression in human amniotic epithelial cell feeder layers maintains human-induced pluripotent stem cell pluripotency via increased leukemia inhibitory factor expression.

Liu T, Chen Q, Huang Y, Huang Q, Jiang L, Guo L.

Acta Biochim Biophys Sin (Shanghai). 2012 Mar;44(3):197-206. doi: 10.1093/abbs/gmr127. Epub 2012 Jan 26.

PMID:
22285730
17.
18.

Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.

Kang NH, Hwang KA, Kim SU, Kim YB, Hyun SH, Jeung EB, Choi KC.

Cancer Gene Ther. 2012 Aug;19(8):517-22. doi: 10.1038/cgt.2012.30. Epub 2012 Jun 1. Review.

PMID:
22653384
19.

MYOD mediates skeletal myogenic differentiation of human amniotic fluid stem cells and regeneration of muscle injury.

Kim JA, Shon YH, Lim JO, Yoo JJ, Shin HI, Park EK.

Stem Cell Res Ther. 2013;4(6):147.

20.

CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Cananzi M, De Coppi P.

Organogenesis. 2012 Jul-Sep;8(3):77-88. doi: 10.4161/org.22426. Epub 2012 Jul 1. Review.

Supplemental Content

Support Center